VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 588 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2015. The put-call ratio across all filers is 2.30 and the average weighting 1.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $35,000 | -99.7% | 2,225 | -99.6% | 0.00% | -100.0% |
| Q4 2017 | $11,411,000 | +130.9% | 545,703 | +57.9% | 0.13% | +113.1% |
| Q3 2017 | $4,942,000 | -25.0% | 345,706 | -9.0% | 0.06% | -29.1% |
| Q2 2017 | $6,591,000 | +57.2% | 379,735 | -0.3% | 0.09% | +72.0% |
| Q1 2017 | $4,194,000 | -33.0% | 380,797 | -11.7% | 0.05% | -41.9% |
| Q4 2016 | $6,263,000 | -93.2% | 431,343 | -88.5% | 0.09% | -94.5% |
| Q3 2016 | $92,429,000 | +156.2% | 3,765,875 | +110.1% | 1.58% | +187.9% |
| Q2 2016 | $36,073,000 | +876.8% | 1,792,788 | +1177.8% | 0.55% | +894.5% |
| Q1 2016 | $3,693,000 | -74.2% | 140,298 | -0.9% | 0.06% | -75.8% |
| Q4 2015 | $14,325,000 | +88.0% | 141,568 | +230.0% | 0.23% | +70.7% |
| Q3 2015 | $7,621,000 | +0.3% | 42,897 | +25.3% | 0.13% | +4.7% |
| Q2 2015 | $7,599,000 | +212.1% | 34,240 | +177.8% | 0.13% | +225.6% |
| Q1 2015 | $2,435,000 | +37.6% | 12,324 | 0.0% | 0.04% | +50.0% |
| Q4 2014 | $1,770,000 | +9.4% | 12,324 | 0.0% | 0.03% | +4.0% |
| Q3 2014 | $1,618,000 | +3.7% | 12,324 | 0.0% | 0.02% | +8.7% |
| Q2 2014 | $1,561,000 | -3.9% | 12,324 | 0.0% | 0.02% | -8.0% |
| Q1 2014 | $1,624,000 | +12.4% | 12,324 | 0.0% | 0.02% | +13.6% |
| Q4 2013 | $1,445,000 | +104.1% | 12,324 | +82.0% | 0.02% | +100.0% |
| Q3 2013 | $708,000 | – | 6,773 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bruce & Co., Inc. | 850,000 | $6,987,000 | 2.38% |